bluebird bio Inc (BLUE) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering bluebird bio Inc.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
BLUE Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- BLUE has a lower variance in analysts' estimates than 3.31999999999999% of all US stocks.
- The number of analysts covering the stock of BLUE is higher than 97.71% of Pharmaceutical Products stocks.
- bluebird bio Inc's upside potential (average analyst target price relative to current price) is higher than 96.07% of stocks in the large market cap category.
- The average analyst price target of BLUE is higher than 89.48% of Pharmaceutical Products stocks.
- BLUE has a less percent of analysts bearish on the stock than nearly 100% of all US stocks.
- The percentage of analysts bullish on the stock of BLUE is greater than just about none of of all US stocks.
- bluebird bio Inc's change in bullishness amongst analysts is lower than nearly 100% of all US stocks.
Is BLUE a Buy, Hold or Sell? See the POWR Ratings now!